• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主动快速分子筛查及感染预防与控制干预措施对单间隔离不足的急诊重症监护病房耐碳青霉烯类感染的疗效

Efficacy of Active Rapid Molecular Screening and IPC Interventions on Carbapenem-Resistant Infections in Emergency Intensive Care Units without Enough Single-Room Isolation.

作者信息

Yang Simin, He Lihua, Li Ke, Yu Xiaoyu, Ni Lijun, Hu Liang, Guo Jian, Biskup Ewelina, Tang Lunxian, Wu Wenjuan

机构信息

Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

Department of Hospital Infection Management, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

出版信息

Infect Drug Resist. 2023 Feb 20;16:1039-1048. doi: 10.2147/IDR.S396331. eCollection 2023.

DOI:10.2147/IDR.S396331
PMID:36845019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9951601/
Abstract

PURPOSE

To investigate whether rapid active molecular screening and infection prevention and control (IPC) interventions can reduce colonization or infection with carbapenem-resistant (CRE) in a general emergency intensive care unit (EICU) without enough single-room isolation.

METHODS

The study was designed as a before-and-after quasi-experiment. Before the experimental period, the ward was rescheduled and the staff were trained. From May 2018 to April 2021, active screening was performed by seminested real-time fluorescent polymerase chain reaction (PCR) detection with rectal swabs from all patients on admission to the EICU, and the results were reported in 1 hour. Other IPC interventions including hand hygiene, contact precautions, patient isolation, environmental disinfection, environment surveillance, monitoring, auditing and feedback were conducted under strict supervision. The patients' clinical characteristics were collected simultaneously.

RESULTS

In this 3-year study, 630 patients were enrolled and 19.84% of the patients were initially colonized or infected with CRE as shown by active molecular screening. The average drug resistance ratio to carbapenem shown by clinical culture detection of (KPN) before the study was performed was 71.43% in EICU. The drug resistance ratio decreased significantly from 75%, 66.67% to 46.67% in the next 3 years (p<0.05) during which active screening and IPC interventions were strictly executed. While the ratio gaps between EICU and the whole hospital were narrowed from 22.81%, 21.11% to 4.64%. Patients with invasive devices, skin barrier damage, and the recent use of antibiotics on admission were found to have a higher risk of being colonized or infected with CRE (p<0.05).

CONCLUSION

Active rapid molecular screening and other IPC interventions may significantly reduce CRE nosocomial infections even in wards without enough single-room isolation. The key to reduce the spread of CRE in the EICU is the strict execution of IPC interventions by all medical staff and healthcare workers.

摘要

目的

探讨在一间没有足够单人隔离病房的普通急诊重症监护病房(EICU)中,快速主动分子筛查和感染预防与控制(IPC)干预措施能否减少耐碳青霉烯类肠杆菌科细菌(CRE)的定植或感染。

方法

本研究设计为准前后对照实验。在实验期前,对病房进行重新规划并对工作人员进行培训。2018年5月至2021年4月,采用半巢式实时荧光聚合酶链反应(PCR)检测对所有入住EICU的患者进行入院时直肠拭子主动筛查,并在1小时内报告结果。在严格监督下实施其他IPC干预措施,包括手卫生、接触预防、患者隔离、环境消毒、环境监测、监测、审核和反馈。同时收集患者的临床特征。

结果

在这项为期3年的研究中,共纳入630例患者,主动分子筛查显示19.84%的患者最初被CRE定植或感染。在进行本研究前,EICU中临床培养检测显示的肺炎克雷伯菌(KPN)对碳青霉烯类的平均耐药率为71.43%。在严格执行主动筛查和IPC干预措施的接下来3年中,耐药率从75%、66.67%显著降至46.67%(p<0.05)。而EICU与全院之间的耐药率差距从22.81%、21.11%缩小至4.64%。发现入住时使用侵入性设备、皮肤屏障受损和近期使用抗生素的患者被CRE定植或感染的风险较高(p<0.05)。

结论

即使在没有足够单人隔离病房的病房中,主动快速分子筛查和其他IPC干预措施也可能显著降低CRE医院感染。减少CRE在EICU传播的关键是所有医务人员和医护人员严格执行IPC干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/9951601/9c1034ab5708/IDR-16-1039-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/9951601/9a9ff09d99b2/IDR-16-1039-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/9951601/5e70dad57971/IDR-16-1039-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/9951601/39ee14e53467/IDR-16-1039-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/9951601/157a7278f496/IDR-16-1039-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/9951601/9c1034ab5708/IDR-16-1039-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/9951601/9a9ff09d99b2/IDR-16-1039-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/9951601/5e70dad57971/IDR-16-1039-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/9951601/39ee14e53467/IDR-16-1039-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/9951601/157a7278f496/IDR-16-1039-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/9951601/9c1034ab5708/IDR-16-1039-g0005.jpg

相似文献

1
Efficacy of Active Rapid Molecular Screening and IPC Interventions on Carbapenem-Resistant Infections in Emergency Intensive Care Units without Enough Single-Room Isolation.主动快速分子筛查及感染预防与控制干预措施对单间隔离不足的急诊重症监护病房耐碳青霉烯类感染的疗效
Infect Drug Resist. 2023 Feb 20;16:1039-1048. doi: 10.2147/IDR.S396331. eCollection 2023.
2
Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant : a 4-year quasi-experimental before-and-after study.感染预防和控制干预措施以减少 ICU 获得性耐碳青霉烯类肠杆菌科细菌定植和感染:一项为期 4 年的准实验前后研究。
Antimicrob Resist Infect Control. 2019 Jan 10;8:8. doi: 10.1186/s13756-018-0453-7. eCollection 2019.
3
Validation and Extrapolation of a Multimodal Infection Prevention and Control Intervention on Carbapenem-Resistant in an Epidemic Region: A Historical Control Quasi-Experimental Study.多模式感染预防与控制干预措施在流行地区对耐碳青霉烯类感染的验证及外推:一项历史性对照准实验研究
Front Med (Lausanne). 2021 Jul 7;8:692813. doi: 10.3389/fmed.2021.692813. eCollection 2021.
4
Prevalence and risk factors of carbapenem-resistant positivity by active screening in intensive care units in the Henan Province of China: A multi-center cross-sectional study.中国河南省重症监护病房主动筛查碳青霉烯类耐药菌阳性的患病率及危险因素:一项多中心横断面研究
Front Microbiol. 2022 Sep 14;13:894341. doi: 10.3389/fmicb.2022.894341. eCollection 2022.
5
The importance of active surveillance of carbapenem-resistant Enterobacterales (CRE) in colonization rates in critically ill patients.重要的是对危重症患者定植率进行碳青霉烯类耐药肠杆菌科(CRE)的主动监测。
PLoS One. 2022 Jan 20;17(1):e0262554. doi: 10.1371/journal.pone.0262554. eCollection 2022.
6
Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.通过严格的接触预防措施成功控制耐碳青霉烯类肠杆菌科细菌,无需主动监测。
Am J Infect Control. 2014 Dec;42(12):1270-3. doi: 10.1016/j.ajic.2014.09.004. Epub 2014 Nov 25.
7
Transmission of Carbapenem-Resistant Enterobacterales in an Overcrowded Emergency Department: Controlling the Spread to the Hospital.在拥挤的急诊部传播碳青霉烯类耐药肠杆菌科:控制向医院的传播。
Clin Infect Dis. 2023 Jul 5;77(Suppl 1):S46-S52. doi: 10.1093/cid/ciad263.
8
Carbapenem-resistant Klebsiella pneumoniae colonization in pediatric and neonatal intensive care units: risk factors for progression to infection.儿科和新生儿重症监护病房中耐碳青霉烯类肺炎克雷伯菌定植:进展为感染的危险因素
Braz J Infect Dis. 2016 Mar-Apr;20(2):134-40. doi: 10.1016/j.bjid.2015.12.004. Epub 2016 Feb 8.
9
Prevalence and risk factors for colonisation and infection with carbapenem-resistant Enterobacterales in intensive care units: A prospective multicentre study.重症监护病房中产碳青霉烯类耐药肠杆菌科细菌定植和感染的流行情况及危险因素:一项前瞻性多中心研究。
Intensive Crit Care Nurs. 2023 Dec;79:103491. doi: 10.1016/j.iccn.2023.103491. Epub 2023 Jul 20.
10
Identification and infection control of carbapenem-resistant Enterobacterales in intensive care units.重症监护病房中耐碳青霉烯类肠杆菌科细菌的鉴定与感染控制
Acute Crit Care. 2021 Aug;36(3):175-184. doi: 10.4266/acc.2021.00409. Epub 2021 Aug 12.

引用本文的文献

1
Incidence and risk factors of active carbapenem-resistant enterobacteriaceae surveillance in hematology patients: a propensity score matching study.血液科患者中耐碳青霉烯类肠杆菌科细菌主动监测的发病率及危险因素:一项倾向评分匹配研究
Front Microbiol. 2025 Jul 16;16:1561587. doi: 10.3389/fmicb.2025.1561587. eCollection 2025.
2
Prevention and control of hospital-acquired infections with multidrug-resistant organism: A review.多重耐药菌医院感染的预防与控制:综述
Medicine (Baltimore). 2024 Jan 26;103(4):e37018. doi: 10.1097/MD.0000000000037018.

本文引用的文献

1
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).美国传染病学会 2022 年关于治疗产超广谱β-内酰胺酶肠杆菌科细菌(ESBL-E)、耐碳青霉烯肠杆菌科细菌(CRE)和治疗困难的耐药铜绿假单胞菌(DTR-P. aeruginosa)的指导意见。
Clin Infect Dis. 2022 Aug 25;75(2):187-212. doi: 10.1093/cid/ciac268.
2
Admission screening and cohort care decrease carbapenem resistant enterobacteriaceae in Vietnamese pediatric ICU's.入院筛查和队列护理可降低越南儿科 ICU 中的碳青霉烯类耐药肠杆菌科。
Antimicrob Resist Infect Control. 2021 Aug 30;10(1):128. doi: 10.1186/s13756-021-00994-9.
3
Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016-2018.泰国 2016-2018 年碳青霉烯类耐药肠杆菌科的分子流行病学研究。
Antimicrob Resist Infect Control. 2021 Jun 5;10(1):88. doi: 10.1186/s13756-021-00950-7.
4
Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use.培养证实的脓毒症中抗生素耐药病原体的流行情况以及与经验性抗生素使用不足和广谱相关的结局。
JAMA Netw Open. 2020 Apr 1;3(4):e202899. doi: 10.1001/jamanetworkopen.2020.2899.
5
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.美国碳青霉烯类耐药肠杆菌科细菌(CRACKLE-2)的分子和临床流行病学:一项前瞻性队列研究。
Lancet Infect Dis. 2020 Jun;20(6):731-741. doi: 10.1016/S1473-3099(19)30755-8. Epub 2020 Mar 6.
6
Present and Future of Carbapenem-resistant (CRE) Infections.耐碳青霉烯类肠杆菌科细菌(CRE)感染的现状与未来
Antibiotics (Basel). 2019 Aug 19;8(3):122. doi: 10.3390/antibiotics8030122.
7
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread.欧洲耐碳青霉烯类肺炎克雷伯菌的流行是由医院内传播驱动的。
Nat Microbiol. 2019 Nov;4(11):1919-1929. doi: 10.1038/s41564-019-0492-8. Epub 2019 Jul 29.
8
Pulsed-field gel electrophoresis (PFGE): A review of the "gold standard" for bacteria typing and current alternatives.脉冲场凝胶电泳 (PFGE):细菌分型的“金标准”及当前替代方法综述。
Infect Genet Evol. 2019 Oct;74:103935. doi: 10.1016/j.meegid.2019.103935. Epub 2019 Jun 22.
9
Management of carbapenem-resistant Enterobacteriaceae infections.碳青霉烯类耐药肠杆菌科感染的管理。
Clin Microbiol Infect. 2019 Aug;25(8):943-950. doi: 10.1016/j.cmi.2019.04.013. Epub 2019 Apr 18.
10
Nation-wide survey of screening practices to detect carriers of multi-drug resistant organisms upon admission to Swiss healthcare institutions.瑞士全国范围内调查医疗机构入院时对多重耐药菌携带者的筛查实践。
Antimicrob Resist Infect Control. 2019 Feb 13;8:37. doi: 10.1186/s13756-019-0479-5. eCollection 2019.